Abstract
The clinicopathologic spectrum of neurothekeoma was elaborated upon relatively recently. As our understanding of its morphologic variability expands, so too does its differential diagnosis. Effective dissection of the differential diagnosis requires recognition of both the classic and variant morphologies, a challenging feat in itself. The remarkable morphologic plasticity exhibited by this peculiar neoplasm lends itself to confusion with various benign and malignant melanocytic and non-melanocytic neoplasms. The collision of neurothekeoma with the notoriously protean melanoma culminates in a perfect storm of diagnostic havoc. Further complicating the diagnosis is a lack of a specific immunoprofile for neurothekeoma, reflecting its uncertain origin and differentiation. Fortunately, the presence or absence of expression of certain markers, such as S100 protein, serves as an invaluable discriminatory tool. As no confirmatory molecular test has surfaced for neurothekeoma, the diagnosis rests on the integration of clinical, histopathologic, and immunohistochemical findings, which are subject to change over time as our understanding of this tumor evolves.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
- 2.
The term “cellular neurothekeoma” was introduced by Barnhill and Mihm [15] as a distinctive subtype of neurothekeoma, but currently, it is best understood as a morphologic pattern on a spectrum of cellular ↔ myxoid rather than as an actual subtype.
- 3.
S100A6 must not be confused with S100 protein, with which it is in the same family [16].
- 4.
SMA-positive cells in desmoplastic melanoma are likely non-lesional cells (reactive stromal myofibroblasts) [58].
References
Weedon D. Weedon’s Skin Pathology. 3rd ed. London: Churchill Livingstone Elsevier; 2010.
Gnepp D, editor. Diagnostic Surgical Pathology of the Head and Neck, 2nd ed. Philadelphia: Saunders Co. (Elsevier); 2009.
Fisher C, Montgomery E, Thway K. In: Epstein J, editor. Biopsy Interpretation of Soft Tissue Tumors. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2011.
Busam K. Dermatopathology. Volume in the series: Foundations in Diagnostic Pathology. Elsevier Health Sciences; 2010 [cited 2014 Feb 15]. Available from: Expert Consult
Weiss SW, Goldblum JR. Benign tumors of peripheral nerves. Enzinger and Weiss’s Soft Tissue Tumors. 5th ed. St. Louis: Mosby; 2007.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2013.
Gallager RL, Helwig EB. Neurothekeoma—a benign cutaneous tumor of neural origin. Am J Clin Pathol. 1980;74(6):759–64.
Pulitzer DR, Reed RJ. Nerve-sheath myxoma (perineurial myxoma). Am J Dermatopathol. 1985;7(5):409–21.
Fetsch JF, Laskin WB, Hallman JR, Lupton GP, Miettinen M. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol. 2007;31(7):1103–14.
Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J Surg Pathol. 2005;29(12):1615–24.
Zelger BG, Zelger B. Cellular “neurothekeoma”: an epithelioid variant of dermatofibroma? Verh Dtsch Ges Pathol. 1998;82:239–45.
Laskin WB, Fetsch JF, Miettinen M. The “neurothekeoma”: immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol. 2000;31(10):1230–41.
Argenyi ZB, LeBoit PE, Santa Cruz D, Swanson PE, Kutzner H. Nerve sheath myxoma (neurothekeoma) of the skin: light microscopic and immunohistochemical reappraisal of the cellular variant. J Cutan Pathol. 1993;20(4):294–303.
Hornick JL, Fletcher CD. Cellular neurothekeoma: detailed characterization in a series of 133 cases. Am J Surg Pathol. 2007;31(3):329–40.
Barnhill RL, Mihm MC. Cellular neurothekeoma. A distinctive variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol. 1990;14(2):113–20.
Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol. 2009;31(5):419–22.
de Giorgi V, Alfaioli B, Franchi A, Gori A, Sestini S, Papi F, et al. Cellular neurothekeoma in a girl: could oestrogens favour the development and growth of this rare tumour? J Eur Acad Dermatol Venereol. 2008;22(9):1149–50.
García-Gutiérrez M, Toussaint-Caire S, González-Sánchez P, Ortiz-Hidalgo C. Multiple desmoplastic cellular neurothekeomas localized to the face of a 16-year-old boy. Am J Dermatopathol. 2010;32(8):841–5.
Mahalingam M, Alter JN, Bhawan J. Multiple cellular neurothekeomas—a case report and review on the role of immunohistochemistry as a histologic adjunct. J Cutan Pathol. 2006;33(1):51–6.
Misago N, Satoh T, Narisawa Y. Cellular neurothekeoma with histiocytic differentiation. J Cutan Pathol. 2004;31(8):568–72.
Stratton J, Billings SD. Cellular neurothekeoma: analysis of 37 cases emphasizing atypical histologic features. Mod Pathol. 2014;27(5):701–10.
Chang SE, Lee TJ, Ro JY, Choi JH, Sung KJ, Moon KC, et al. Cellular neurothekeoma with possible neuroendocrine differentiation. J Dermatol. 1999;26(6):363–7.
Page RN, King R, Mihm MC, Googe PB. Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol. 2004;17(2):230–4.
Sheth S, Li X, Binder S, Dry SM. Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis. Mod Pathol. 2011;24(3):343–54.
Zedek DC, White WL, McCalmont TH. Desmoplastic cellular neurothekeoma: clinicopathological analysis of twelve cases. J Cutan Pathol. 2009;36(11):1185–90.
D’Antonio A, Cuomo R, Angrisani B, Memoli D, Angrisani P. Desmoplastic cellular neurothekeoma mimicking a desmoplastic melanocytic tumor. J Am Acad Dermatol. 2011;65(2):e57–8.
Busam KJ, Mentzel T, Colpaert C, Barnhill RL, Fletcher CD. Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol. 1998;22(9):1067–72.
Cardoso J, Calonje E. Cellular neurothekeoma with perineural extension: a potential diagnostic pitfall. J Cutan Pathol. 2012;39(6):662–4.
Goette DK. Calcifying neurothekeoma. J Dermatol Surg Oncol. 1986;12(9):958–60.
Rooney MT, Nascimento AG, Tung RL. Ossifying plexiform tumor. Report of a cutaneous ossifying lesion with histologic features of neurothekeoma. Am J Dermatopathol. 1994;16(2):189–92.
Fullen DR, Lowe L, Su LD. Antibody to S100a6 protein is a sensitive immunohistochemical marker for neurothekeoma. J Cutan Pathol. 2003;30(2):118–22.
Wang AR, May D, Bourne P, Scott G. PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol. 1999;23(11):1401–7.
Fried I, Sitthinamsuwan P, Muangsomboon S, Kaddu S, Cerroni L, McCalmont TH. SOX-10 and MiTF expression in cellular and ‘mixed’neurothekeoma. J Cutan Pathol. 2014.
Busam KJ, Iversen K, Coplan KC, Jungbluth AA. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol. 2001;25(2):197–204.
Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol. 2001;23(3):185–9.
Folpe AL, Cooper K. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors. Arch Pathol Lab Med. 2007;131(10):1517–24.
Sachdev R, Sundram UN. Frequent positive staining with NKI/C3 in normal and neoplastic tissues limits its usefulness in the diagnosis of cellular neurothekeoma. Am J Clin Pathol. 2006;126(4):554–63.
Campbell LK, Thomas JR, Lamps LW, Smoller BR, Folpe AL. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol. 2003;16(10):963–9.
Wartchow EP, Goin L, Schreiber J, Mierau GW, Terella A, Allen GC. Plexiform fibrohistiocytic tumor: ultrastructural studies may aid in discrimination from cellular neurothekeoma. Ultrastruct Pathol. 2009;33(6):286–92.
Calonje E, Wilson-Jones E, Smith NP, Fletcher CD. Cellular ‘neurothekeoma’: an epithelioid variant of pilar leiomyoma? Morphological and immunohistochemical analysis of a series. Histopathology. 1992;20(5):397–404.
Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology. 2000;36(5):387–402.
Patel P, Levin K, Waltz K, Helm KF. Myxoid melanoma: immunohistochemical studies and a review of the literature. J Am Acad Dermatol. 2002;46(2):264–70.
Hitchcock MG, McCalmont TH, White WL. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis. Am J Surg Pathol. 1999;23(12):1506–13.
Hitchcock MG, White WL. Malicious masquerade: myxoid melanoma. Semin Diagn Pathol. 1998;15(3):195–202.
Ulamec M, Soldo-Belić A, Vucić M, Buljan M, Kruslin B, Tomas D. Melanoma with second myxoid stromal changes after personally applied prolonged phototherapy. Am J Dermatopathol. 2008;30(2):185–7.
Zelger BG, Steiner H, Wambacher B, Zelger B. Malignant melanomas simulating various types of soft tissue tumors. Dermatol Surg. 1997;23(11):1047–54.
Collina G, Losi L, Taccagni GL, Maiorana A. Myxoid metastases of melanoma: report of three cases and review of the literature. Am J Dermatopathol. 1997;19(1):52–7.
Dal Pozzo V, Benelli C, Restano L, Gianotti R, Cesana BM. Clinical review of 247 case records of Spitz nevus (epithelioid cell and/or spindle cell nevus). Dermatology. 1997;194(1):20–5.
Weedon D. The Spitz Naevus. Clin Oncol. 1984;3(3):493–507.
Piepkorn M. On the nature of histologic observations: the case of the Spitz nevus. J Am Acad Dermatol. 1995;32(2 Pt 1):248–54.
Mérot Y, Frenk E. Spitz nevus (large spindle cell and/or epithelioid cell nevus). Age-related involvement of the suprabasal epidermis. Virchows Arch A Pathol Anat Histopathol. 1989;415(2):97–101.
Binder SW, Asnong C, Paul E, Cochran AJ. The histology and differential diagnosis of Spitz nevus. Semin Diagn Pathol. 1993;10(1):36–46.
Spatz A, Peterse S, Fletcher CD, Barnhill RL. Plexiform spitz nevus: an intradermal spitz nevus with plexiform growth pattern. Am J Dermatopathol. 1999;21(6):542–6.
Hoang MP. Myxoid Spitz nevus. J Cutan Pathol. 2003;30(9):566–8.
Heenan P, Maize J, Cook M, LeBoit P. Persistent melanoma and local metastasis of melanoma. In: LeBoit P, Burg G, Weedon D, Sarasin A, editors. Pathology and genetics of skin tumours. IARC WHO Classification of Tumours. Lyon: IARC Press; 2005. p. 90–2.
Cassarino DS, Cabral ES, Kartha RV, Swetter SM. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol. 2008;144(1):49–56.
de Almeida LS, Requena L, Rütten A, Kutzner H, Garbe C, Pestana D, et al. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol. 2008;30(3):207–15.
Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol. 1996;20(12):1489–500.
Prieto VG, Shea CR. Immunohistochemistry of melanocytic proliferations. Arch Pathol Lab Med. 2011;135(7):853–9.
Prieto VG, Kanik A, Salob S, McNutt NS. Primary cutaneous myxoid melanoma: immunohistologic clues to a difficult diagnosis. J Am Acad Dermatol. 1994;30(2 Pt 2):335–9.
Calonje E, Blessing K, Glusac E, Strutton G. Blue naevi. In: LeBoit P, Burg G, Weedon D, Sarasin A, editors. Pathology and genetics of skin tumours. IARC WHO classification of tumours. Lyon: IARC Press; 2005. p. 95–9.
Rongioletti F, Innocenzi D. Sclerosing ‘mucinous’ blue naevus. Br J Dermatol. 2003;148(6):1250–2.
Luzar B, Calonje E. Deep penetrating nevus: a review. Arch Pathol Lab Med. 2011;135(3):321–6.
Harris GR, Shea CR, Horenstein MG, Reed JA, Burchette JL, Prieto VG. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23(7):786–94.
Vollmer RT. Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma. Am J Clin Pathol. 2004;122(4):499–505.
National Cancer Institute. SEER stat fact sheets: melanoma of the skin [Internet] [cited 2014 Feb 12]. Available from: http://seer.cancer.gov/statfacts/html/melan.html.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Paral, K.M., Reed, J.A., Prieto, V.G., Shea, C.R. (2015). Neurothekeoma Versus Melanoma. In: Shea, C., Reed, J., Prieto, V. (eds) Pathology of Challenging Melanocytic Neoplasms. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1444-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1444-9_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1443-2
Online ISBN: 978-1-4939-1444-9
eBook Packages: MedicineMedicine (R0)